Interrater reliability of extrapyramidal signs in a group assessed for dementia

M. Richards, K. Marder, K. Bell, G. Dooneief, R. Mayeux and Y. Stern
Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, NY.

Extrapyramidal signs were rated by three neurologists in 20 patients who had either been diagnosed as having probable Alzheimer's disease or who were being evaluated for dementia. In general, good interrater reliability was found for the presence or absence of extrapyramidal signs, although agreement over the presence of some signs was reduced when distinctions between normality and slight departures from normality were required.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Concurrent Validity of Neuropsychiatric Subgroups on Caregiver Burden in Alzheimer Disease Patients
Tun et al.
AJGP 2008;16:594-602.
ABSTRACT | FULL TEXT  

Predictive Validity of Neuropsychiatric Subgroups on Nursing Home Placement and Survival in Patients With Alzheimer Disease
Tun et al.
AJGP 2007;15:314-327.
ABSTRACT | FULL TEXT  

The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease.
Stavitsky et al.
Arch Neurol 2006;63:1450-1456.
ABSTRACT | FULL TEXT  

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Zhu et al.
Neurology 2006;67:998-1005.
ABSTRACT | FULL TEXT  

Clinical features associated with costs in early AD: Baseline data from the Predictors Study
Zhu et al.
Neurology 2006;66:1021-1028.
ABSTRACT | FULL TEXT  

Single-dose Levodopa Administration and Aging Independently Disrupt Time Production.
Rakitin et al.
J. Cogn. Neurosci. 2006;18:376-387.
ABSTRACT | FULL TEXT  

Relation of Quantitative Indexes of Concurrent {alpha}-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease
Holtzer et al.
Arch Neurol 2006;63:226-230.
ABSTRACT | FULL TEXT  

Motor signs predict poor outcomes in Alzheimer disease
Scarmeas et al.
Neurology 2005;64:1696-1703.
ABSTRACT | FULL TEXT  

Motor signs during the course of Alzheimer disease
Scarmeas et al.
Neurology 2004;63:975-982.
ABSTRACT | FULL TEXT  

The impact of parkinsonism on costs of care in patients with AD and dementia with Lewy bodies
Murman et al.
Neurology 2003;61:944-949.
ABSTRACT | FULL TEXT  

The incremental direct costs associated with behavioral symptoms in AD
Murman et al.
Neurology 2002;59:1721-1729.
ABSTRACT | FULL TEXT  

Cerebrovascular Disease Affects Noncognitive Symptoms in Alzheimer Disease
Frisoni et al.
Arch Neurol 2001;58:1939-1940.
FULL TEXT  

Extrapyramidal symptoms and signs in Alzheimer's disease: Pravalence and correlation with the first symptom
Tsolaki et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2001;16:268-278.
ABSTRACT  

An Investigation of Clinical Correlates of Lewy Bodies in Autopsy-Proven Alzheimer Disease
Stern et al.
Arch Neurol 2001;58:460-465.
ABSTRACT | FULL TEXT  

The Neurologic Examination in Adult Psychiatry: From Soft Signs to Hard Science
Sanders and Keshavan
J. Neuropsychiatry Clin. Neurosi. 1998;10:395-404.
ABSTRACT | FULL TEXT  

Determinants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders
Sweet et al.
J. Neuropsychiatry Clin. Neurosi. 1998;10:68-77.
ABSTRACT | FULL TEXT  

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano et al.
NEJM 1997;336:1216-1222.
ABSTRACT | FULL TEXT